agilon health, inc. (NYSE:AGL) Position Cut by Stifel Financial Corp

Stifel Financial Corp lessened its holdings in shares of agilon health, inc. (NYSE:AGL) by 41.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 10,875 shares of the company’s stock after selling 7,607 shares during the quarter. Stifel Financial Corp’s holdings in agilon health were worth $43,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of AGL. Citigroup Inc. raised its stake in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares in the last quarter. AQR Capital Management LLC raised its position in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after acquiring an additional 174,883 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its stake in agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in agilon health by 6.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 640,048 shares of the company’s stock worth $2,515,000 after buying an additional 37,725 shares during the last quarter.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research report on Wednesday, October 2nd. Citigroup cut their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. Finally, TD Cowen lowered their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $4.28.

agilon health Stock Up 0.5 %

Shares of NYSE:AGL opened at $1.91 on Tuesday. The company has a market capitalization of $786.95 million, a PE ratio of -2.03 and a beta of 0.51. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $13.28. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company’s fifty day moving average is $2.18 and its 200-day moving average is $4.05.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the firm earned ($0.06) earnings per share. Equities research analysts predict that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Diana Mckenzie purchased 12,500 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were bought at an average price of $2.28 per share, with a total value of $28,500.00. Following the purchase, the director now directly owns 51,319 shares in the company, valued at $117,007.32. This trade represents a 32.20 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 90,000 shares of company stock worth $198,100 in the last 90 days. Corporate insiders own 3.20% of the company’s stock.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.